Since the results of bioinformatic analysis and clinical specimens showed that QSOX2 overexpression was associated with the malignant progression of CRC patients, we will focus on the biological function of QSOX2 in CRC. The gene discussed is QSOX2; the disease is colorectal carcinoma.